COLUMBIA, Mo. (AP) — University of Missouri researchers have developed a potential new stroke treatment that targets an enzyme critical to brain function.
Zezong Gu is an assistant professor of pathology and anatomical sciences at the university’s School of Medicine. His research team has developed a drug that could delay the onset of a type of stroke that occurs when blood clots block blood flow to the brain.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.